关注
Rajasekhar Chikati
Rajasekhar Chikati
Yogi Vemana University
在 yvu.edu.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Exploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: A docking and …
M Chaitanya, B Babajan, CM Anuradha, M Naveen, C Rajasekhar, ...
Journal of molecular modeling 16, 1357-1367, 2010
432010
Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells—an in vitro and in silico study
SL Pandrangi, R Chikati, PS Chauhan, CS Kumar, A Banarji, S Saxena
Tumor Biology 35, 723-737, 2014
372014
Role of dietary iron revisited: In metabolism, ferroptosis and pathophysiology of cancer
SL Pandrangi, P Chittineedi, R Chikati, JR Lingareddy, M Nagoor, ...
American journal of cancer research 12 (3), 974, 2022
312022
Protein-protein docking on molecular models of Aspergillus niger RNase and human actin: novel target for anticancer therapeutics
RK Gundampati, R Chikati, M Kumari, A Sharma, DD Pratyush, ...
Journal of molecular modeling 18, 653-662, 2012
282012
Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking
CM Anuradha, C Mulakayala, B Babajan, M Naveen, C Rajasekhar, ...
Journal of molecular modeling 16, 77-85, 2010
262010
Role of lipoproteins in the pathophysiology of breast cancer
SL Pandrangi, P Chittineedi, R Chikati, JAN Mosquera, SNS Llaguno, ...
Membranes 12 (5), 532, 2022
182022
Molecular docking and dynamics simulations of A.niger RNase from Aspergillus niger ATCC26550: for potential prevention of human cancer
GR Kumar, R Chikati, SL Pandrangi, M Kandapal, K Sonkar, N Gupta, ...
Journal of molecular modeling 19, 613-621, 2013
172013
β-N-oxalyl-L-α, β-diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions
RK Eslavath, D Sharma, NAMB Omar, R Chikati, MK Teli, GK Rajanikant, ...
European Journal of Pharmacology 791, 405-411, 2016
132016
Novel antiviral effects of chloroquine, hydroxychloroquine, and green tea catechins against SARS CoV-2 main protease (Mpro) and 3C-like protease for COVID-19 treatment
FB Shaik, K Swarnalatha, MC Mohan, A Thomas, R Chikati, G Sandeep, ...
Clinical Nutrition Open Science 42, 62-72, 2022
122022
Molecular studies on evaluation of phytol as cytoskeleton targeting element in cancer
R Chikati, LS Pandrangi, R Gundampati, SH Vemuri, M Lakhanpal, ...
Int. J. Sci. Eng. Res 9 (10), 1978-1992, 2018
92018
Characterization and molecular modeling of polygalacturonase isoforms from Saccharomyces cerevisiae
V Poondla, R Chikati, M Kallubai, V Chennupati, R Subramanyam, ...
3 Biotech 7, 1-13, 2017
72017
Homology modeling and molecular docking of heme peroxidase from Euphorbia tirucalli: Substrate specificity and thiol inhibitor interactions
A Shukla, RK Gundampati, C Rajasekhar, MV Jagannadham
Journal of Molecular Liquids 220, 383-394, 2016
52016
Microwave‐Assisted Synthesis of 4‐Aryl‐1,4‐dihydropyridines as Potent Anticancer Agent and Their In‐Silico Studies
R Kumar, N Yadav, H Jain, N Deswal, RK Upadhyay, A Leekha, ...
ChemistrySelect 7 (19), e202104129, 2022
42022
Molecular docking analysis of imine stilbene analogs and evaluation of their anti-aging activity using yeast and mammalian cell models
R Naini, R Chikati, DR Vudem, RK Kancha
Journal of Receptors and Signal Transduction 39 (1), 55-59, 2019
42019
In silico effective inhibition of galtifloxacin on built Mtb-DNA gyrase
D Gowsia, B Babajan, M Chaitanya, C Rajasekhar, P Madhusudana, ...
Journal of Bioinformatics and Sequence Analysis 1 (4), 050-055, 2009
42009
Structural characterization of pfSerine hydroxymethyltransferase: A novel target for malaria
R Chikati, CM Anuradha, M Chaitanya, B Babajan, PY Prasad, CS Kumar
Journal of Bioinformatics and Sequence Analysis 2 (2), 13-24, 2010
22010
Protein-Protein Docking on Molecular Models of RNase of Aspergillus niger and Actin of Homo sapiens: Novel target for Anticancer Therapeutics
RK Gundampati, R Chikati, CS Kumar, MD Das
Journal of Biotechnology, 424, 2010
2010
Computational binding mechanism of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (MurA) with inhibitors fosfomycin, cyclic disulfide analog RWJ-3981 …
CM Anuradha, B Babajan, M Chaitanaya, C Rajasekhar, SK Chitta
Nature Precedings, 1-1, 2009
2009
Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking
B Babajan, M Naveen, C Rajasekhar, CS Kumar
2009
Molecular characterization of sulfate adenylytransferase subunit2 and its inhibitors by comparative modeling and docking studies
R Chikati
Anantapur, 0
系统目前无法执行此操作,请稍后再试。
文章 1–20